FDA Inspection
David Boyer, MDDavid Boyer, MD – FDA Inspection, Apr 4, 2012
Record Details
This FDA Inspection record concerns David Boyer, MD, with an inspection on April 4, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David Boyer, MD
- Inspection Date
- April 4, 2012
- Product Type
- Drugs
View Company Profile
ID · 62b47000-bcc4-42f4-872f-8536914350f3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 775647
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David Boyer, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 26, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David Boyer, MD
- FDA Inspection 1207331 - 2023-05-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.